作　　者： (漆洪波）; (郑静）;

机构地区： 重庆医科大学附属第一医院妇产科、重庆医科大学“中国-加拿大-新西兰”联合母胎医学实验室,重庆400016

出　　处： 《重庆医科大学学报》 2017年第8期925-928,共4页

摘　　要： 巨大儿(macrosomia)是产科临床常见的现象,随着新生儿出生体质量增加,异常分娩、肩难产及产伤等发生率随之增加。目前临床缺乏产前准确诊断巨大儿的方法。2016年11月美国妇产科医师学会(The American College of Obstetricians and Gynecologists,ACOG)发布了巨大儿指南[1]。该指南的目的是量化巨大儿的风险,评价测量胎儿体质量方法的准确性及局限性,以及对疑似巨大儿的临床管理。本文对其要点进行解读。 Suspected fetal macrosomia is encountered commonly in obstetric practice. As birth weight increases,the likelihood of labor abnormalities,shoulder dystocia,birth trauma,and permanent injury to the neonate increases. However,the diagnosis of fetal macrosomia is imprecise. The American College of Obstetricians and Gynecologists issued guidelines for the management of fetal macrosomia.The purpose of this document is to quantify those risks,address the accuracy and limitations of methods for estimating fetal weight,and suggest clinical management for a pregnancy with suspected fetal macrosomia.

关 键 词： 巨大儿 肩难产 剖宫产